Skip to main content

Joaquin Ruiz Altarejo

Institutions of which they are part

Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca
Joaquin Ruiz Altarejo

Joaquin Ruiz Altarejo

Joaquin Ruiz Altarejo

Institutions of which they are part

Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Related news

The project aims to improve prevention, diagnosis, and treatment through computational biomedicine, innovative therapies, and the transfer of knowledge into clinical practice.

The annual event offered a space for dialogue between the scientific community and society on how to address the future of ageing through research and innovation.

Docetaxel, carried by Soluplus, proved to be the most effective and least toxic combination to cross the blood-brain barrier and attack the tumour directly.

Related professionals

Sara Ajanovic Andelic

Sara Ajanovic Andelic

Predoctoral researcher
Infection and immunity in pediatric patients
Read more
Silvia Mora Marco

Silvia Mora Marco

Cardiovascular Diseases
Read more
Vicenta Pujol Blaya

Vicenta Pujol Blaya

Predoctoral researcher
Research Group of Physical Medicine and Rehabilitation
Read more
Pablo Palaín Poncelas

Pablo Palaín Poncelas

Digital Transformation Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.